Results of long-term follow-up of patients with HIV/tuberculosis coinfection
- Autores: Vdoushkina E.S.1, Borodulin B.E.1, Eremenko E.P.1
-
Afiliações:
- Samara State Medical University, Ministry of Health of Russia
- Edição: Volume 34, Nº 6 (2023)
- Páginas: 52-54
- Seção: From Practice
- URL: https://ogarev-online.ru/0236-3054/article/view/250480
- DOI: https://doi.org/10.29296/25877305-2023-06-10
- ID: 250480
Citar
Acesso aberto
Acesso está concedido
Somente assinantes
Resumo
The problem of combined HIV/tuberculosis infection is characterized by a broad social orientation, a serious risk factor for the development of the disease and a factor of death is the use of narcotic substances. The number of patients with HIV/tuberculosis co-infection in the Russian Federation remains high, the majority of cases of tuberculosis in patients with HIV infection are detected in the late stages of the disease, mainly when patients turn to the general treatment network. In recent years, the situation has been complicated by an increase in the proportion of cases of sexual transmission of HIV, the number of infected among young women is growing. The problem of drug resistance of Mycobacterium tuberculosis creates many difficulties in terms of diagnosis and treatment. The course of the tuberculosis process in HIV patients, due to pronounced immunosuppression, is often atypical, TB diagnosis is especially difficult at the stage of severe immunodeficiency, the tuberculosis process often proceeds in a generalized form. Treatment of comorbid patients is also a big problem due to the simultaneous administration of a large number of anti-tuberculosis drugs in addition to their lifelong HIV treatment, which leads to a decrease in adherence to treatment. The article presents data from an 11-year follow-up of a cohort of patients with HIV infection and tuberculosis. The clinical and anamnestic data, the experience of HIV infection, the timing and causes of deaths were evaluated. The patients were mainly young men (70%) with a high level of intravenous drug use (77.5%), high hepatitis C virus infection (55%), severe immunosuppression (60.1%), a significant proportion of MDR (43.8%), lack of adherence to antiretroviral therapy (58.8%). 51.25% of patients died during the follow-up period. Due to the high risks of death and other failures of tuberculosis treatment in patients with HIV/TB comorbidity, studies of the results of management of such patients in the long term remain a priority for all regions of the country. The problem of detecting tuberculosis in patients with HIV-infection remains urgent, which requires the interaction of both the phthisiological service and infectious disease specialists, narcologists and primary health care.
Palavras-chave
Texto integral
##article.viewOnOriginalSite##Sobre autores
E. Vdoushkina
Samara State Medical University, Ministry of Health of Russia
Email: borodulinbe@yandex.ru
Candidate of Medical Sciences
Rússia, SamaraB. Borodulin
Samara State Medical University, Ministry of Health of Russia
Autor responsável pela correspondência
Email: borodulinbe@yandex.ru
ORCID ID: 0000-0002-6676-8587
Doctor of Medical Sciences, Professor
Rússia, SamaraE. Eremenko
Samara State Medical University, Ministry of Health of Russia
Email: borodulinbe@yandex.ru
ORCID ID: 0000-0001-5909-4070
Candidate of Medical Sciences, Associate Professor
Rússia, SamaraBibliografia
- Бородулина Е., Вдоушкина Е., Инькова А. Туберкулез легких у больных ВИЧ-инфекцией. Врач. 2020; 31 (1): 37–43 [Borodulina E., Vdoushkina E., Inkova A. Tuberculosis and HIV-infection. Vrach. 2020; 31 (1): 37–43 (in Russ.)]. doi: 10.29296/25877305-2020-01-07
- Бородулина Е.А., Кудлай Д.А., Кузнецова А.Н. и др. Использование технологической платформы ELISPOT в диагностике туберкулезной инфекции у пациентов с ВИЧ-инфекцией. Иммунология. 2021; 42 (4): 395–402 [Borodulina E.A., Kudlay D.A., Kuznetsova A.N. et al. The use of the ELISPOT technological platform in the diagnosis of tuberculosis infection in patients with HIV infection. Immunologiya. 2021; 42 (4): 395–402 (in Russ.)]. doi: 10.33029/0206-4952-2021-42-4-395-402
- Бородулина Е.А., Скворцова Е.С., Бородулин Б.Е., Туберкулез у ВИЧ-инфицированных лиц, принимающих наркотики в практике врача-фтизиатра. Медицинский альманах. 2014; 2 (32): 68–71 [Borodulina E.A., Skvortsova E.S., Borodulin B.E. Tuberculosis of hiv-infected drug addicts in the practice of a phthisiatrician. Medical Almanac. 2014; 2 (32): 68–71 (in Russ.)].
- Нечаева О.Б. Социально значимые инфекционные заболевания, представляющие биологическую угрозу населению России. Туберкулез и болезни легких. 2019; 97(11): 7–17 [Nechaeva O.B. Socially important infectious diseases posing a biological threat to the population of Russia. Tuberculosis and Lung Diseases. 2019; 97 (11): 7–17 (in Russ.)]. doi: 10.21292/2075-1230-2019-97-11-7-17
- Каминский Г.Д., Кудлай Д.А., Панова А.Е. и др. Тактика врача при выявлении, диагностике и профилактике сочетанной инфекции ВИЧ и туберкулез. Практическое руководство. Под ред. И.А. Васильевой. М., 2020; 152 с. [Kaminskii G.D., Kudlay D.A., Panova A.E. et al. Taktika vracha pri vyyavlenii, diagnostike i profilaktike sochetannoi infektsii VICh i tuberkulez. Prakticheskoe rukovodstvo. Pod red. I.A. Vasil'evoi. M., 2020; 152 р. (in Russ.)].
- Козлов В.А., Тихонова Е.П., Савченко А.А. и др. Клиническая иммунология. Практическое пособие для инфекционистов. Красноярск: Поликор, 2021; 563 c. [Kozlov V.A., Tikhonova E.P., Savchenko A.A. et al. Klinicheskaya immunologiya. Prakticheskoe posobie dlya infektsionistov. Krasnoyarsk: Polikor, 2021; 563 р. (in Russ.)]. doi: 10.17513/np.438
- Гуляева Н.А., Слепцова С.С., Адамова В.Д. Анализ течения инфильтративного туберкулеза легких у женщин. Восточно-Европейский научный журнал. 2021; 10-3 (74): 18–22 [Gulyaeva N.A., Sleptsova S.S., Adamova V.D. Analysis of the course of infiltrative pulmonary tuberculosis in women. East European Scientific Journal. 2021; 10-3 (74): 18–22 (in Russ.)]. doi: 10.31618/ESSA.2782-1994.2021.3.74.142
- Васильева И.А., Белиловский Е.М., Борисов С.Е. и др. Туберкулез, сочетанный с ВИЧ-инфекцией, в странах мира и в Российской Федерации. Туберкулез и болезни легких. 2017; 95 (9): 8–18 [Vаsilyevа I.A., Belilovsky E.M., Borisov S.E. et al. Tuberculosis with concurrent HIV infection in the Russian Federation and the world. Tuberculosis and Lung Diseases. 2017; 95 (9): 8–18 (in Russ.)]. doi: 10.21292/2075-1230-2017-95-9-8-18
- Бородулина Е.А., Вдоушкина Е.С., Бородулин Б.Е. и др. Социальный портрет больных ВИЧ-инфекцией и тяжелой внебольничной пневмонией. Инфекционные болезни. 2018; 16 (3): 20–5 [Borodulina E.A., Vdoushkina E.S., Borodulin B.E. et al. A social portrait of patients with HIV infection and severe community-acquired pneumonia. Infectious diseases. 2018; 16 (3): 20–5 (in Russ.)]. doi: 10.20953/1729-9225-2018-3-20-25
- Бородулина Е.А., Маткина Т.Н., Вдоушкина Е.С. Причины смерти больных ВИЧ-инфекцией и туберкулезом. Туберкулез и болезни легких. 2015; 5: 44–5 [Borodulina E.A., Matkina T.N., Vdoushkina E.S. Causes of death of patients with HIV infection and tuberculosis. Tuberculosis and Lung Diseases. 2015; 5: 44–5 (in Russ.)].
- De Vries G., van de Berg S., van Dam A. et al. Collaborative tuberculosis/HIV activities in the European Region. ERJ Open Res. 2021; 7(1): 00721-2020. doi: 10.1183/23120541.00721-2020
- Загдын З.М. Двойная инфекция ВИЧ/туберкулез. Особенности распространения на Северо-Западе России. Туберкулез и социально-значимые заболевания. 2019; 1: 50–7 [Zagdyn Z.M. HIV/TB coinfection. its spread features in the North-West region of Russia. Tuberculosis and Socially Significant Diseases. 2019; 1: 50–7 (in Russ.)].
Arquivos suplementares
